We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+4.63%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$921M
AUM Growth
-$85.5M
Cap. Flow
-$110M
Cap. Flow %
-11.98%
Top 10 Hldgs %
14.09%
Holding
5,143
New
1,384
Increased
1,284
Reduced
1,171
Closed
1,233

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$11.2M
2
XOM icon
ExxonMobil
XOM
+$10.8M
3
AAPL icon
Apple
AAPL
+$10.8M
4
IBB icon
iShares Biotechnology ETF
IBB
+$10.2M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$8.12M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$265M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$98.3M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$32.7M
4
VNQ icon
Vanguard Real Estate ETF
VNQ
+$18.2M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$14.9M

Sector Composition

Rank Sector Weight
1 Financials 13.75%
2 Technology 8.29%
3 Industrials 7.33%
4 Healthcare 6.94%
5 Consumer Discretionary 6.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CTB
1351
DELISTED
Cooper Tire & Rubber Co.
CTB
$57K 0.01%
+1,466
New +$55.2K
CVG
1352
DELISTED
Convergys
CVG
$57K 0.01%
2,329
-6,286
-73% -$169K
CLCD
1353
DELISTED
CoLucid Pharmaceuticals, Inc.
CLCD
$57K 0.01%
+1,571
New +$55.6K
CLNE icon
1354
Clean Energy Fuels
CLNE
$410M
$56K 0.01%
+19,447
New +$73.4K
KYNB
1355
Kyntra Bio
KYNB
$28.3M
$56K 0.01%
105
+101
+2,525% +$50.4K
FTK icon
1356
Flotek Industries
FTK
$1.32B
$56K 0.01%
999
+971
+3,468% +$70.9K
GEM icon
1357
Goldman Sachs ActiveBeta Emerging Markets Equity ETF
GEM
$1.7B
$56K 0.01%
+2,080
New +$57.2K
IMKTA icon
1358
Ingles Markets
IMKTA
$1.65B
$56K 0.01%
+1,160
New +$51.7K
JNUG icon
1359
Direxion Daily Junior Gold Miners Index Bull 2X ETF
JNUG
$461M
$56K 0.01%
+50
New +$88.7K
KELYA icon
1360
Kelly Services Class A
KELYA
$542M
$56K 0.01%
2,420
+1,956
+422% +$39.8K
LECO icon
1361
Lincoln Electric
LECO
$15.2B
$56K 0.01%
737
-1,145
-61% -$82K
UBS icon
1362
UBS Group
UBS
$173B
$56K 0.01%
3,564
-1,449
-29% -$21.8K
WBD icon
1363
Warner Bros
WBD
$66.2B
$56K 0.01%
+2,025
New +$54.9K
TPC
1364
Tutor Perini Cor
TPC
$5.04B
$56K 0.01%
2,010
+1,910
+1,910% +$46.3K
CBD
1365
DELISTED
Companhia Brasileira de Distribuicao
CBD
$56K 0.01%
3,363
+1,899
+130% +$31.5K
PFPT
1366
DELISTED
Proofpoint, Inc.
PFPT
$56K 0.01%
787
+720
+1,075% +$54.2K
FPRX
1367
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$56K 0.01%
1,123
+1,073
+2,146% +$56.4K
JOY
1368
DELISTED
Joy Global Inc
JOY
$56K 0.01%
1,988
-3,156
-61% -$88.2K
CWCO icon
1369
Consolidated Water Co
CWCO
$479M
$55K 0.01%
+5,124
New +$56.5K
GTLS
1370
DELISTED
Chart Industries
GTLS
$55K 0.01%
+1,527
New +$52K
ING icon
1371
ING
ING
$102B
$55K 0.01%
3,942
+2,874
+269% +$38.7K
JJSF icon
1372
J&J Snack Foods
JJSF
$1.72B
$55K 0.01%
410
+408
+20,400% +$50.3K
KN icon
1373
Knowles
KN
$3.36B
$55K 0.01%
3,324
+2,035
+158% +$31.7K
MSM icon
1374
MSC Industrial Direct
MSM
$6.92B
$55K 0.01%
599
-719
-55% -$59.3K
RMBS icon
1375
Rambus
RMBS
$10.6B
$55K 0.01%
+3,972
New +$51.4K
53 54
55
56 57

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
GAMH
Greenwoods Asset Management (HK) Hong Kong $3.88B AUM 23.82% 1-Year Est. Return
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Tower Research Capital (TRC)'s Q4 2016 Portfolio in Review

As of Q4 2016, Tower Research Capital (TRC) held 5,143 positions worth $921M, down 8.5% from $1.01B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Tower Research Capital (TRC) withdrew a net $110M in Q4 2016, closing 1,233 positions and reducing 1,171 holdings. Its most notable exit was Vanguard Real Estate ETF, an estimated $18.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 3.3% a quarter earlier, followed by Technology and Industrials.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Biotechnology ETF worth $9.93M.

  • Tower Research Capital (TRC)'s largest Q4 2016 buy was iShares Biotechnology ETF: 112,296 shares worth $9.93M.
  • Tower Research Capital (TRC) added most to Microsoft in Q4 2016, an estimated $11.2M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $265M.
  • Tower Research Capital (TRC) fully exited Vanguard Real Estate ETF in Q4 2016, selling an estimated $18.2M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $921M portfolio in Q4 2016.
  • Tower Research Capital (TRC) opened 1,384 new positions and closed 1,233 in Q4 2016.
  • Tower Research Capital (TRC)'s portfolio value fell 8.5% quarter-over-quarter to $921M.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2016, filed 3 Feb 2017.